1,668
Views
65
CrossRef citations to date
0
Altmetric
Review

Herbal treatments for alleviating premenstrual symptoms: a systematic review

&
Pages 42-51 | Received 28 Feb 2010, Accepted 03 Nov 2010, Published online: 21 Dec 2010

References

  • Reid R. Premenstrual syndrome. N Engl J Med 1991;324:1208–1210.
  • ACOG Diagnostic Criteria for PMS. ACOG Practice Bulletin – Number 15, 2000.
  • Mortola J. Premenstrual syndrome-pathophysiologic considerations. N Engl J Med 1998;338:256–257.
  • Singh BB, Berman BM, Simpson RL, Annechild A. Incidence of premenstrual syndrome and remedy usage: a national probability sample study. Altern Ther Health Med 1998;4:75–79.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994. pp 715–718.
  • Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder-clinical procedures and research perspectives. Gynecol Endocrinol 2004;19:320.
  • O'Brien PM. Helping women with premenstrual syndrome. BMJ 1993;307:1471–1475.
  • Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 1998;129:229–240.
  • Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev 2009;15:CD006586.
  • Ford O, Lethaby A, Roberts H, Mol BW. Progesterone for premenstrual syndrome. Cochrane Database Syst Rev 2009;15:CD003415.
  • Brown J, O' Brien PM, Marjoribanks J, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2009;15:CD001396.
  • Wyatt KM, Dimmock PW, Jones PW, Shaughn O, Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 1999;318:1375–1381.
  • MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996;347:569–573.
  • Corney RH, Stanton R. A survey of 658 women who report symptoms of premenstrual syndrome. J Psychosom Res 1991;35:471–482.
  • Lloyd KB, Hornsby LB. Complementary and alternative medications for women's health issues. Nutr Clin Pract 2009;24:589–608.
  • Himmel W, Schulte M, Kochen MM. Complementary medicine: are patients’ expectations being met by their general practitioners? Br J Gen Pract 1993;43:232–235.
  • Eisenberg DM, Davis RB, Ettner SL, Appel S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998;280:1569–1575.
  • Tesch BJ. Herbs commonly used by women. An evidence-based review. Am J Obstet Gynecol 2003;188:S44–S45.
  • Stevinson C, Ernst E. Complementary/alternative therapies for premenstrual syndrome: a systematic review of randomized controlled trials. Am J Obstet Gynecol 2001;185:227–235.
  • Whelan AM, Jurgens TM, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol 2009;16:407–429.
  • Cho SH, Kim J. Efficacy of acupuncture in management of premenstrual syndrome: a systematic review. Complement Ther Med 2010;18:104–111.
  • Lampert N, Xu Y. Chinese herbal nephropathy. Lancet 2002;359:796–797.
  • Gruenwald J, Brendler T, Jaenicke C, editors. PDR for herbal medicines. 2nd edition. Montvale, New Jersey: Medical Economics Company; 2000.
  • Jadad AR, Carroll D, Moore A, McQuay H. Developing a database of published reports of randomised clinical trials in pain. Research Pain 1996:66:239–246.
  • Jadad AR, McQuay HJ. A high-yield strategy to identify randomized controlled trials for systematic reviews. Online J Curr Clin Trials 1993:27; Doc. No. 33.
  • Mortola JF, Girton L, Beck L, Yen SS. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol 1990;76:302–307.
  • Carver CS, Scheier MF, Weintraub JJ. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol 1989;56:267–283.
  • Gerhard I, Patek A, Monga B, Blank A, Gorkow C. Mastodynon (R) bei weiblicher Sterilitaet. Forsch Komplementarmed 1998;5:272–278.
  • Westphal LM, Polan ML, Trant AS, Mooney SB. A nutritional supplement for improving fertility in women: a pilot study. J Reprod Med 2004;49:289–293.
  • Cerin A, Collins A, Landgren BM, Eneroth P. Hormonal and biochemical profiles of premenstrual syndrome. Treatment with essential fatty acids. Acta Obstet Gynecol Scand 1993;72:337–343.
  • Halaska M, Raus K, Beles P, Martan A, Paithner KG. Treatment of cyclical mastodynia using an extract of Vitex agnus castus: results of a double-blind comparison with a placebo. Ceska Gynekol 1998;63:388–392.
  • Van Die MD, Bone KM, Burger HG, Reece JE, Teede HJ. Effects of a combination of Hypericum perforatum and Vitex agnus castus on PMs-like symptoms in late perimenopausal women: findings from a subpopulation analysis. J Altern Complement Med 2009;15:1045–1048.
  • Milewicz A, Gejdel E, Sworen H, Sienkiewicz K, et al. Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study Arzneimittelforschung 1993;43:752–756.
  • Ma L, Lin S, Chen R, Zhang Y, Chen F, Wang X. Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Aust NZJ Obstet Gynecol 2010;50:189–193.
  • Hunter JO, Wilson AJ. A double-blind controlled trial of gamma-linolenic acid (GLA) in the management of pre-menstrual gastrointestinal symptoms. Proceedings of 2nd International Symposium on Premenstrual, Postpartum and Menopausal Mood Disorders, Kiawah Island, South Carolina; 1987. Abstract 44.
  • Halaska M, Beles P, Gorkow C, Sieder C. Treatment of cyclical mastalgia with a solution containing a Vitex agnus castus extract: results of a placebo-controlled double-blind study. The Breast 1993;8:175–218.
  • Shellemberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ 2001;322:134–137.
  • Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol Clin Exp 2003;18:191–195.
  • Lauritzen CH, Reuter HD, Repges R, et al. Treatment of premenstrual tension syndrome with Vitex agnus castus: controlled, double-blind study versus pyridoxine. Phytomedicine 1997;4:183–189.
  • Turner S, Mills S. A double-blind clinical trial on a herbal remedy for premenstrual syndrome: a case study. Complement Ther Med 1993;1:73–77.
  • Kilicdag EB, Tarim E, Bagis T, Erkanli S, et al. Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia. Int J Gynecol Obstet 2004;85:292–293.
  • He Z, Chen R, Zhou Y, Geng L, Zhang Z, et al. Treatment for premenstrual syndrome with Vitex agnus castus: a prospective, randomized, multi-center placebo controlled study in China. Maturitas 2009;63:99–103.
  • Ma L, Lin S, Chen R, Zhang Y, Chen F, Wang X. Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Aust N Z J Obstet Gynaecol 2010;50:189–193.
  • Callender K, Mc Gregor M, Kirk P, Thomas CS. A double blind trial of evening primerose oil in the premenstrual syndrome: nervous symptoms subgroup. Hum Psychopharmacol 1988;3:57–61.
  • Khoo SK, Munro C, Battistutta D. Evening primrose oil and treatment of premenstrual syndrome. Med J Aust 1990;153:189–192.
  • Collins A, Cerin A, Coleman G, Landgren B-M. Essential fatty acids in the treatment of premenstrual syndrome. Obstet Gynecol 1993;81:93–98.
  • Puolakka J, Makirainen L, Viinikka L, Ylikorkala O. Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. J Reprod Med 1985;30:149–153.
  • Hicks SM, Walker AF, Gallagher J, Middleton RW, Wright J. The significance of “nonsignificance” in randomized controlled studies: a discussion inspired by a double-blinded study on St. John's wort (Hypericum perforatum L.) for premenstrual symptoms. J Altern Complement Med 2004;10:925–932.
  • Canning S, Waterman M, Orsi N, Ayres J, Simpson N, Dye L. The efficacy of Hypericum perforatum (St John's Wort) for the treatment of premenstrual syndrome. A randomized, double-blind, placebo-controlled trial. CNS Drugs 2010;24:207–225.
  • Tamborini A, Taurelle R. Value of standardized Ginkgo biloba extract (Egb 761) in the management of congestive symptoms of premenstrual syndrome. Rev Fr Gynecol Obstet 1993;88:447–457.
  • Ozgoli G, Selselei EA, Mojab F, Majd HA. A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome. J Altern Complement Med 2009;15:845–851.
  • Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreishi A, et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG 2008;115:515–519.
  • Jarry H, Leonhardt S, Gorkow C, Wuttke W. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol 1994;102:448–454.
  • Rotblatt M, Ziment I, editors. Evidence-based herbal medicine. Philadelphia: Hanley & Belfus Publ; 2002.
  • Brush MG, Watson SJ, Horrobin DF, Manku MS. Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome. Am J Obstet Gynecol 1984;150:363–366.
  • Graham J. Premenstrual syndrome: evening primrose oil. Thorsens 1984:36–40.
  • Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St. John's Wort in major depression: a randomized placebo controlled trial. JAMA 2001;285:1978–1986.
  • Laakmann G, Schule C, Baghai T, et al. St. John's Wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiat 1998;31:54–59.
  • Pang Z, Pan F, He S. Ginkgo biloba L.: history, current status, and future prospects. J Altern Complement Med 1996;2:359–363.
  • McKenna DJ, Jones K, Hughes K. Efficacy, safety, and use of Ginkgo Biloba in clinical and preclinical applications. Altern Ther Health Med 2001;7:70–90.
  • Noorbala AA, Akhondzadeh S, Tamacebi-pour N, Jamshidi AH. Hydroalcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J Ethnopharmacol 2005;97:281–284.
  • Akhondzadeh S, Tamacebi-pour N, Noorbala AA, Amini H, Fallah Pour H, Jamshidi AH, et al. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo controlled trial. Phytother Res 2005;19:25–29.
  • Wang Y, Han T, Zhu Y, Zheng CJ, Ming QL, Rahman K, Qin LP. Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. J Nat Med 2010;64:24–30.
  • Monagle L, Dan A, Krogh V, Jossa F, Farinaro E, Trevisan M. Perimenstrual symptom prevalence rates: an Italian-American comparison. Am J Epidemiol 1993;138:1070–1081.
  • Borrelli F, Izzo AA. Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. AAPS J 2009;11:710–727.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.